EANM Dosimetry Committee guidance document: Good practice of clinical dosimetry reporting

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 1, 2011, Pages 192-200

  Lassmann, M ^a   Chiesa, C ^b   Flux, G ^c   Bardies M ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d Département de Recherche en Cancérologie Nantes Angers   (France)

Author keywords

Dosimetry; Reporting; Targeted radiotherapy

Indexed keywords

ARTICLE; CALIBRATOR; CHECKLIST; DOSIMETRY; EANM DOSIMETRY COMMITTEE; FOOD AND DRUG ADMINISTRATION; HUMAN; KINETICS; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RECORD; MOLECULAR PROBE; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PROFESSIONAL STANDARD; QUANTITATIVE ANALYSIS; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CALIBRATION; DIAGNOSTIC IMAGING; DOCUMENTATION; GAMMA CAMERAS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; NEOPLASMS; PHANTOMS, IMAGING; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; RESEARCH DESIGN;

EID: 79551557533     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1549-3     Document Type: Article

References (28)

1. 131I therapy in non-Hodgkin's lymphoma J Nucl Med 46 Suppl 1 128S 140S 1:CAS:528:DC%2BD2MXhsVeksbw%3D 15653661
2. 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma Cancer Biother Radiopharm 20 195 199 1:CAS:528:DC%2BD2MXjsl2lsLw%3D 10.1089/cbr.2005.20.195 15869455 (Pubitemid 40696102)
3. M Noseda GR McLean 2008 Where did the scientific method go? Nat Biotechnol 26 28 29 1:CAS:528:DC%2BD1cXisFGrsg%3D%3D 10.1038/nbt0108-28 18183010
4. E Busemann Sokole A Plachcinska A Britten M Lyra Georgosopoulou W Tindale R Klett 2010 Routine quality control recommendations for nuclear medicine instrumentation Eur J Nucl Med Mol Imaging 37 662 671 10.1007/s00259-009-1347-y 20130859
5. 131I diagnostic activities on the biokinetics of thyroid remnants J Nucl Med 45 619 625 15073258
6. L Jonsson M Ljungberg SE Strand 2005 Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom J Nucl Med 46 1679 1686 16204718
7. B He Y Du WP Segars RL Wahl G Sgouros H Jacene, et al. 2009 Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake Med Phys 36 612 619 10.1118/1.3063156 19292001
8. 90Y-ibritumomab tiuxetan radioimmunotherapy of patients with non-Hodgkin's lymphoma Cancer Biother Radiopharm 23 53 64 10.1089/cbr.2007.372 18298329 (Pubitemid 351304220)
9. D Vriens EP Visser LF de Geus-Oei WJ Oyen 2010 Methodological considerations in quantification of oncological FDG PET studies Eur J Nucl Med Mol Imaging 37 1408 1425 10.1007/s00259-009-1306-7 19936745
10. RJ Jaszczak CE Floyd RE Coleman 1985 Scatter compensation techniques for SPECT IEEE Trans Nucl Sci 32 786 793 10.1109/TNS.1985.4336941
11. T Ichihara K Ogawa N Motomura A Kubo S Hashimoto 1993 Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT J Nucl Med 34 2216 2221 1:STN:280:DyaK2c%2Fns1Sksw%3D%3D 8254414
12. W Jentzen 2010 Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging Phys Med Biol 55 2365 98 10.1088/0031-9155/55/8/016 20360631
13. W Jentzen R Weise J Kupferschlager L Freudenberg W Brandau R Bares, et al. 2008 Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems Eur J Nucl Med Mol Imaging 35 611 623 10.1007/s00259-007-0554-7 17929014 (Pubitemid 351661669)
14. RF Hobbs S Baechler S Van Senthamizhchel AR Prideaux CE Esaias M Reinhardt, et al. 2010 A gamma camera count rate saturation correction method for whole-body planar imaging Phys Med Biol 55 817 831 1:CAS:528: DC%2BC3cXjtFOhurw%3D 10.1088/0031-9155/55/3/018 20071766
15. C Chiesa A Negri C Albertini R Azzeroni E Setti L Mainardi, et al. 2009 A practical dead time correction method in planar activity quantification for dosimetry during radionuclide therapy Q J Nucl Med Mol Imaging 53 658 670 1:STN:280:DC%2BD1MfjtVKmtA%3D%3D 20016456
16. 124I imaging on a Philips Gemini dual GS PET/CT system Eur J Nucl Med Mol Imaging 36 1037 1048 10.1007/s00259-009-1099-8 19288099
17. S Walrand F Jamar I Mathieu J De Camps M Lonneux M Sibomana, et al. 2003 Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86 Eur J Nucl Med Mol Imaging 30 354 361 1:CAS:528:DC%2BD3sXitFGmtLc%3D 10.1007/s00259-002-1068-y 12634962
18. M Lassmann H Hänscheid C Chiesa C Hindorf G Flux M Luster 2008 EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy Eur J Nucl Med Mol Imaging 35 1405 1412 10.1007/s00259-008-0761-x 18491092
19. GD Flux MJ Guy R Beddows M Pryor MA Flower 2002 Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy Phys Med Biol 47 3211 3223 10.1088/0031-9155/47/17/311 12361219
20. A Divoli A Spinelli S Chittenden D Dearnaley G Flux 2005 Whole-body dosimetry for targeted radionuclide therapy using spectral analysis Cancer Biother Radiopharm 20 66 71 1:CAS:528:DC%2BD2MXisVShtrY%3D 10.1089/cbr.2005.20. 66 15778583 (Pubitemid 40478524)
21. G Glatting P Kletting SN Reske K Hohl C Ring 2007 Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test Med Phys 34 4285 4292 1:CAS:528:DC%2BD2sXht1yntrzJ 10.1118/1.2794176 18072493 (Pubitemid 350029650)
22. WE Bolch KF Eckerman G Sgouros SR Thomas 2009 MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry-standardization of nomenclature J Nucl Med 50 477 484 1:CAS:528:DC%2BD1MXktVyns7k%3D 10.2967/jnumed.108.056036 19258258
23. A Divoli S Chiavassa L Ferrer J Barbet GD Flux M Bardies 2009 Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies J Nucl Med 50 316 323 10.2967/jnumed.108.056705 19164237
24. International Commission on Radiation Units 2002 Absorbed-dose specifications in nuclear medicine J ICRU 2 5 110
25. MG Stabin RB Sparks E Crowe 2005 OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J Nucl Med 46 1023 1027 15937315
26. D Grosev S Loncaric D Huic D Dodig 2008 Geometric models in dosimetry of thyroid remnant mass Nuklearmedizin 47 120 126 1:STN:280:DC%2BD1czptVajtQ%3D%3D 18493692
27. RG Dale 1996 Dose-rate effects in targeted radiotherapy Phys Med Biol 41 1871 1884 1:STN:280:DyaK2s%2FmvFaitw%3D%3D 10.1088/0031-9155/41/10/001 8912367 (Pubitemid 26333627)
28. JA O'Donoghue 1999 Implications of nonuniform tumor doses for radioimmunotherapy J Nucl Med 40 1337 1341 10450686